Charles Andrew Daly

Charles Andrew Daly

Auto-generated profile, based on publicly available information

Charles Andrew Daly

Department of Orthopaedic Surgery, Emory University, Atlanta, GA

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 July 2021 in JBJS Open Access
Verified
Journal Article
Open access
KFKevin X. Farley
Kevin X. Farley
JWJacob M. Wilson
Jacob M. Wilson
AKAnjali Kumar
Anjali Kumar
MGMichael B. Gottschalk
Michael B. Gottschalk
CDCharles Daly
Charles Daly
EWEric R. Wagner
Eric R. Wagner
Background: Existing data on the epidemiology of shoulder arthroplasty are limited to future projections of incidence. However, the prevalence of shoulder arthroplasty (the number of individuals with a shoulder arthroplasty alive at a certain time and its implications for the burden of revision procedures) remains undetermined for the United States. Hence, the purpose of this study was to estimate the prevalence of shoulder arthroplasty in the United States. Methods: The National Inpatient Sample (NIS) was queried to count all patients who underwent total shoulder arthroplasty (TSA), including both anatomic and reverse TSA, and hemiarthroplasty between 1988 and 2017. The counting method was used to calculate the current prevalence of TSA and hemiarthroplasty using age and sex-specific population and mortality data from the U.S. Census Bureau. Results: In 2017, an estimated 823,361 patients (95% confidence interval [CI], 809,267 to 837,129 patients) were living in the United States with a shoulder replacement. This represents a prevalence of 0.258%, increasing markedly from 1995 (0.031%) and 2005 (0.083%). Female patients had a higher prevalence at 0.294% than male patients at 0.221%. Over 2% of people who were ≥80 years of age in the United States were living with a shoulder replacement. Furthermore, approximately 60% of patients living with a shoulder replacement had undergone the operation between 2013 and 2017. The incidence of revision shoulder arthroplasty is increasing on an annual basis, with 10,290 revision procedures performed in 2017, costing the U.S. health-care system $205 million. Conclusions: The prevalence of shoulder arthroplasty in the United States has markedly increased over time. This trend will likely continue given increasing life expectancies and exponentially increasing shoulder arthroplasty incidence rates. Most patients do not have long-term follow-up, and revision shoulder arthroplasty rates are increasing, a trend that is projected to continue. The data from our study highlight the enormous public health impact of shoulder replacement and shed light on a potentially increasing revision burden.

1 December 2019 in The Journal of Hand Surgery
Verified
Journal Article
Closed access
RHRussell E. Holzgrefe
Russell E. Holzgrefe
EWEric R. Wagner
Eric R. Wagner
ASAdam D. Singer
Adam D. Singer
CDCharles A. Daly
Charles A. Daly

1 December 2016 in The Journal of Hand Surgery
Verified
Journal Article
Closed access
MDMihir J. Desai
Mihir J. Desai
CDCharles A. Daly
Charles A. Daly
JSJohn G. Seiler
John G. Seiler
WWWalter H. Wray
Walter H. Wray
DRDavid S. Ruch
David S. Ruch
FLFraser J. Leversedge
Fraser J. Leversedge

22 January 2020 in Journal of Bone and Joint Surgery
Verified
Journal Article
Closed access
KFKevin X. Farley
Kevin X. Farley
ASAndrew M. Schwartz
Andrew M. Schwartz
SBSusanne H. Boden
Susanne H. Boden
CDCharles A. Daly
Charles A. Daly
MGMichael B. Gottschalk
Michael B. Gottschalk
EWEric R. Wagner
Eric R. Wagner
Background: As the utilization of reverse total shoulder arthroplasty (RSA) grows, it is increasingly important to examine the relationship between hospital volume and RSA outcomes. We hypothesized that hospitals that perform a higher volume of RSAs would have improved outcomes. We also performed stratum-specific likelihood ratio (SSLR) analysis with the aim of delineating concrete definitions of hospital volume for RSA. Methods: The Nationwide Readmissions Database was queried for patients who had undergone elective RSA from 2011 to 2015. Annual hospital volume and 90-day outcome data were collected, including readmission, revision, complications, hospital length of stay (LOS), supramedian cost, and discharge disposition. SSLR analysis was performed to determine hospital volume cutoffs associated with increased risks for adverse events. Cutoffs generated through SSLR analysis were confirmed via binomial logistic regression. Results: The proportion of patients receiving care at high-volume centers increased from 2011 to 2015. SSLR analysis produced hospital volume cutoffs for each outcome, with higher-volume centers showing improved outcomes. The volume cutoffs associated with the best rates of 90-day outcomes ranged from 54 to 70 RSAs/year, whereas cost and resource utilization cutoffs were higher, with the best outcomes in hospitals performing >100 RSAs/year. SSLR analysis of 90-day readmission produced 3 hospital volume categories (1 to 16, 17 to 69, and ≥70 RSAs/year), each significantly different from each other. These were similar to the strata for 90-day revision (1 to 16, 17 to 53, and ≥54 RSAs/year) and 90-day complications (1 to 9, 10 to 68, and ≥69 RSAs/year). SSLR analysis produced 6 hospital volume categories for cost of care over the median value (1 to 5, 6 to 25, 26 to 47, 48 to 71, 72 to 105, and ≥106 RSAs/year), 5 categories for an extended LOS (1 to 10, 11 to 25, 26 to 59, 60 to 105, and ≥106 RSAs/year), and 4 categories for non-home discharge (1 to 31, 32 to 71, 72 to 105, and ≥106 RSAs/year). Conclusions: We have defined hospital surgical volumes that maximize outcomes after RSA, likely related to surgical experience, ancillary staff familiarity, and protocolized pathways. This information may be used in future policy decisions to consolidate complex procedures, such as RSA, at high-volume destinations, or to encourage lower-volume institutions to strategize an approach to function as a higher-volume center. Level of Evidence: Therapeutic Level IV. See Instructions for Authors for a complete description of levels of evidence.

1 August 2022 in The Journal of Hand Surgery
Verified
Journal Article
Closed access
PGPaul T. Greenfield
Paul T. Greenfield
CSCorey C. Spencer
Corey C. Spencer
ADAlexander Dawes
Alexander Dawes
EWEric R. Wagner
Eric R. Wagner
MGMichael B. Gottschalk
Michael B. Gottschalk
CDCharles A. Daly
Charles A. Daly

16 December 2022 in Journal of Hand Surgery Global Online
Verified
Journal Article
Open access
KMKatherine McGurk
Katherine McGurk
JTJoseph Anthony Tracey
Joseph Anthony Tracey
DDDane N. Daley
Dane N. Daley
CDCharles Andrew Daly
Charles Andrew Daly
Peripheral nerve compression of the upper extremity is a common pathology often necessitating surgical intervention, much is known, but much more is left to understand. For the more common pathologies, carpal tunnel syndrome, cubital tunnel syndrome, and ulnar tunnel syndrome, research and clinical efforts directed toward standardization and reduction of resource use have been attempted with varied success. Diagnosis of many of these syndromes is largely based on a proper history and physical examination. Electrodiagnostic studies continue to have value, but proportionally less than previous decades. In addition, emerging technologies, including magnetic resonance neurography, novel ultrasound evaluation techniques, and ultrasound-guided diagnostic injections, are beginning to demonstrate their ability to add value to the diagnostic algorithm, particularly when less common compressive neuropathies are present and/or the diagnosis is in question.